Our strength is in our breadth
THE BREADTH OF OUR membersHIPS:
PLATINUM MEMBERS
AUSTRALIAN NATURAL THERAPEUTICS GROUP
AUSTRALIAN NATURAL THERAPEUTICS GROUP
AUSTRALIAN NATURAL THERAPEUTICS GROUP
Australian Natural Therapeutics Group is a GMP, GACP certified independent producer of exclusive, pharmaceutical-grade medicinal cannabis products for patients worldwide.
ANTG is focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
ANTG produces exclusive high-quality cannabinoid based medicinal treatments to meet individual patient needs. It combines a strong research focus with best-in-class cultivation and extraction methods. Led by a board of skilled commercial leaders, the ANTG team includes experienced horticulturists, scientific researchers and medical advisors.
ANTG’s passion for the plant underpins its focus on putting the needs of patients first – and believes it is uniquely positioned to achieve more and be more for the benefit of humanity.
AUSTRALIAN NATURAL THERAPEUTICS GROUP
AUSTRALIAN NATURAL THERAPEUTICS GROUP
MiDispensary is an Australian based telehealth clinic, dedicated to helping those in need to access quality plant-based therapy.
MiDispensary's doctors and nurses have a wide experience in health issues and chronic medical problems as well as extensive knowledge of the latest research in the benefits of medicinal cannabis.
MiDispensary's parent company, The Entourage Effect, operates as a secure and reliable dispensary, allowing popular medical cannabis products to be more accessible and affordable for patients.
GOLD MEMBERS
Beacon Medical Australia is a wholly-owned subsidiary of VIVO Cannabis. Indoor, small batch, GMP production facilities produce premium quality, consistent products with strict standards including craft-like conditions, specially curated genetics and NO pesticides.
Beacon Medical Australia's mission is to advance patient care with innovative cannabinoid-based therapeutic products, developed to support and fulfil individuals unique health needs.
BOD Australiais a CBD and Hemp healthcare company.
By leading the way in research and development, the mission of BOD Australiais to innovate and transform the way we live and enjoy life through the delivery of premium, proven and trusted global products for consumers and healthcare professionals.
Inspired from its work in research, clinical trials and partnerships, BOD Australia is expanding its suite of pharmaceutical-grade, medicinal cannabis for distribution in Australia with new markets now being opened worldwide.
Canngea Pty Ltd was incorporated in Sydney, Australia in 2017.
Canngea's mission is to bridge the gap between ancient and contemporary medicine for a better quality of life. Canngea's vision is to be the leading medical cannabis manufacturer, storage and wholesale distributor in Australasia.
Canngea operates globally in partnership with S4 and S8 storage and distributors, manufacturers, cultivators and brand owners and is committed to undertaking research and development (R&D) activities that can bring additional value to its business partners.
Medifarm Tikun has changed its name to Tikun Australia, but remains proudly 100% Australian.
Tikun Australia is proud to partner with Tikun Olam, pioneers and world leaders in medicinal cannabis, to provide Australian patients with the most advanced medical cannabis treatments, supported by global research into plant science, manufacturing, and therapeutic outcome
Tikun Australia has an outstanding team who bring with them knowledge and experience, across a multitude of departments and are passionate about what they do.
SILVER MEMBERS
Austranna is a fully licensed Australian-owned cultivator and manufacturer of plant-based medicines.
Austranna’s mission is to change the face of healthcare by delivering medicines that empower those in need with safe access to premium quality medical grade products.
Austranna partners with major compounding pharmacies across Australia to ensure reliable supplies of high quality medical grade compounding ingredients at affordable prices.
Cymra Life Sciences is an Australian-owned licenced cultivator and manufacturer of medical cannabis.
Cymra Life Sciences has two clear goals:
- to register a clinical cannabis product for chronic pain; and
- to develop and supply cannabis genetics to the cannabis industry worldwide.
Cymra Life Sciences is the only cannabis company in Australia focusing on genetic development and supply to cannabis cultivators.
Green Farmers is a B2B technology enabled medicinal grade cultivator focused on medicinal cannabis supplying Australia’s leading brands with high quality flower.
With 4,000 sqm protected cropping facility Green Farmers delivers quality, consistency, and surety of supply cultivating either their customers genetics or providing their own range - enabling Australian brands to focus on the patient with locally grown medicinal cannabis.
HealthCare Cloud is an expanding Australian company that is dedicated to empowering Medical Practices through the use of Cloud Platform Technology.
HealthCare Cloud delivers a managed service for Medical Practices through an Online and Remotely accessible Workspace designed for Practice Software and Business Solutions.
HealthCare Cloud's customers have benefited from the unique and innovative solutions it offers to Australian Medical Practices.
Holmes Wilson is a specialist consultancy dedicated to assisting the medicinal cannabis and allied industries to navigate the Australian pharmaceutical environment and regulatory standards of development, registration, communication and supply.
As industries for emerging therapies mature, evolving medical and regulatory environments become increasingly complex. Previously uncharted territory presents a challenge for patients, health professionals, suppliers, regulatory bodies and related industries.
iX Syrinx is an expanding global company that is dedicated to improving health outcomes for its clients.
iX Syrinx is a fully integrated business providing end-to-end product development and manufacturing services for pharmaceutical and nutraceutical products.
iX Syrinx's scientists combine formulation know-how and oral, topical or sublingual delivery technologies to create unique and innovative solutions for pharmaceutical use and consumer health.
Based in regional Australia, Medical Cannabis Australia Pty Ltd is a family owned and operated cultivator, manufacturer and exporter of medical cannabis plants and products.
Using eco-friendly, off-grid power solutions, MCA's facility produces cost-effective, superior quality, medical grade cannabis for wholesale distribution across Australia and the world.
MCA's products are cultivated to meet strict Australian and European GACP and GMP conditions.
MedTEC Pharma was founded to lead the medicinal cannabis industry on a path to delivering an evidence-based medicine; trusted by health professionals and accessible by those needing relief from chronic conditions.
MedTEC Pharma is committed to delivering world-leading, bred-for-purpose medicinal cannabis. Its pathway to this objective includes partnerships with some of the leading research institutions in Australia and the world.
Founded in 2017, Oz Medicann Group (OMG) is a licensed medicinal cannabis healthcare company with a core focus on improving patient access to medicinal cannabis and health outcomes for consumers.
OMG aims to build Australia’s largest medicinal cannabis, education and hemp consumables companies and to expand its core medical solutions through research and development with university partners, acquisitions and imports.
Scitek is the only ANZ based specialist cannabis manufacturing equipment supplier.
Its focus is on providing honest instrument selection advice, combined with benchmark service.
Scitek exclusively represents top brands, which have been picked for outstanding product features and demonstrated product quality.
Unlike the vast majority of laboratory instrumentation providers, the team at Scitek has more service engineers and application scientists than salespeople.
NOT FOR PROFIT MEMBERS
BRONZE MEMBERS
AMCA'S FIRST MEMBERS!
First organisational member - United in Compassion
First organisational member - United in Compassion
First organisational member - United in Compassion
The founder of United in Compassion, the leading NGO for medicinal cannabis, Lucy Haslam is also a founding member, Board Director and Chair of AMCA.
Passionate about access and affordability for patients, Lucy registered UIC (https://unitedincompassion.com.au/), as a member organisation of AMCA as soon as it was formed, and will work through both associations to advocate for, and further the interests of, patients in need.
Lucy continues to campaign tirelessly and, as well as organising the highly successful and well attended 2022 UIC Symposium which has just been held on the Sunshine Coast, she has also been instrumental in driving the development of the online Australian Medicinal Cannabis Course For Health Professionals which was launched at the symposium (https://medicalcannabiscourse.com.au)
We are currently welcoming other organisations to become members to help us to shape the future of our industry for the benefit of the sector and the patients and carers that it serves.
First individual member - Jodie Davis
First organisational member - United in Compassion
First organisational member - United in Compassion
.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:600,h:300,cg:true)
Jodie was the first person to sign up for individual membership on the day that AMCA launched - 15th July 2020
Jodie is, in her own words, a "huge advocate for medicinal cannabis". As well as being a member of United in Compassion, Jodie is Federal Education Officer of the Australian Nursing and Midwifery Federation and has been charged with developing a conference (post-Covid 19) for nurses and midwives about Medicinal Cannabis. She has also written an education piece for nurses and midwives which is available on the online education portal (http://anmf.org.au/education).
We look forward to welcoming many more individuals to join AMCA and its member organisations to make this unique treatment more accessible and affordable. for patients.